Intracerebral Hemorrhage News and Research

RSS
Intracerebral hemorrhage (ICH) is sudden, catastrophic bleeding that occurs in the brain tissue or ventricles. It usually results from damage to blood vessels due to hypertension. Symptoms are often sudden and severe. Loss of consciousness, vomiting, and headache are all common, but milder presentations are also possible, resembling ischemic stroke.
Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

ACRO calls for sufficient resources for FDA to monitor foreign clinical trials

ACRO calls for sufficient resources for FDA to monitor foreign clinical trials

Ricerca announces services under U.S. DEA license

Ricerca announces services under U.S. DEA license

Results from ICH compliant Phase II study of MRX-4 presented at EAACI Congress

Results from ICH compliant Phase II study of MRX-4 presented at EAACI Congress

ACRO unveils survey findings on decline in physician participation in clinical research

ACRO unveils survey findings on decline in physician participation in clinical research

EKOS receives $2.7M grant to develop product for treatment of ICH

EKOS receives $2.7M grant to develop product for treatment of ICH

Morria Biopharmaceuticals to present Phase II study results of MRX-4 at EAACI Congress

Morria Biopharmaceuticals to present Phase II study results of MRX-4 at EAACI Congress

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Transition Therapeutics reports increased revenue in third-quarter 2010

Transition Therapeutics reports increased revenue in third-quarter 2010

Generex Biotechnology enrolls over 400 subjects in global Phase III study of Generex Oral-lyn

Generex Biotechnology enrolls over 400 subjects in global Phase III study of Generex Oral-lyn

RayBiotech announces biomarker grant winners

RayBiotech announces biomarker grant winners

Repros Therapeutics announces response to FDA critique on proposed Phase II Androxal study

Repros Therapeutics announces response to FDA critique on proposed Phase II Androxal study

Sanofi Pasteur accelerates deployment of Intercim's Pertinence Suite MOM software solution

Sanofi Pasteur accelerates deployment of Intercim's Pertinence Suite MOM software solution

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

Access Pharmaceuticals, bioRASI sign collaborative agreement to develop Cobalamin oral insulin product

Malvern exhibits proven PAT solutions for real-time particle sizing at Interphex 2010

Malvern exhibits proven PAT solutions for real-time particle sizing at Interphex 2010

Patients taking warfarin who develop acute stroke more likely to experience brain hemorrhage

Patients taking warfarin who develop acute stroke more likely to experience brain hemorrhage

FDA issues final guidance to help develop safe and effective cell-based viral vaccines

FDA issues final guidance to help develop safe and effective cell-based viral vaccines

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

SNI clinical study using ultrasound for treatment of ICH and IVH presented at International Stroke Conference

SNI clinical study using ultrasound for treatment of ICH and IVH presented at International Stroke Conference

PAREXEL International, Proteome Sciences form biomarker alliance

PAREXEL International, Proteome Sciences form biomarker alliance